Rmnd5b-flox Mouse

Rmnd5b is a member of the CTLH (carboxy-terminal to LisH) complex, a mammalian macromolecular complex with E3-ligase enzymatic activity. The CTLH complex is involved in fundamental biological processes such as proliferation, survival, programmed cell death, cell adhesion, and migration, and interacts with key signaling pathways like PI3-kinase, WNT, TGFβ, and NFκB [1].

In esophageal squamous cell carcinoma (ESCC), bioinformatic analysis identified RMND5B as a prognosis-related gene, and the high-risk group based on the risk score including RMND5B was more responsive to immunotherapy [2]. In pancreatic adenocarcinoma (PAAD), a ZNF family genes-related risk score model including RMND5B was constructed, and the risk score was a significant independent prognostic factor [3]. In acute myeloid leukemia (AML), a prognostic model including RMND5B was established, which accurately predicted AML prognosis [4].

In conclusion, RMND5B, as part of the CTLH complex, is involved in multiple fundamental biological processes and key signaling pathways. Its role in ESCC, PAAD, and AML prognosis, as revealed through bioinformatic analysis and model-based research, highlights its importance in understanding these diseases and potentially developing new treatment strategies.